APA

van Gorkom B. A. P., Timmer-Bosscha H., de Jong S., van der Kolk D. M., Kleibeuker J. H. & de Vries E. G. E. (20020611). Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. : British journal of cancer.

Chicago

van Gorkom B A P, Timmer-Bosscha H, de Jong S, van der Kolk D M, Kleibeuker J H and de Vries E G E. 20020611. Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. : British journal of cancer.

Harvard

van Gorkom B. A. P., Timmer-Bosscha H., de Jong S., van der Kolk D. M., Kleibeuker J. H. and de Vries E. G. E. (20020611). Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. : British journal of cancer.

MLA

van Gorkom B A P, Timmer-Bosscha H, de Jong S, van der Kolk D M, Kleibeuker J H and de Vries E G E. Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. : British journal of cancer. 20020611.